Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

Background Immune checkpoint inhibitors (ICI) have transformed cancer treatment over the last decade. Alongside this therapeutic improvement, a new variety of side effects has emerged, called immune-related adverse events (irAEs), potentially affecting any organ. Among these irAEs, myocarditis is ra...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Isabelle Serre, Olivier Lambotte, Stephane Ederhy, Jean-Marie Michot, Jean-Luc Faillie, Alexandre Thibault Jacques Maria, Xavier Quantin, Candice Lesage, Patricia Rullier, Philippe Guilpain, Romaric Larcher, Kada Klouche, Gerald Chanques, Mathieu Puyade, François Roubille, Nahéma Issa, Olivier Dereure, Cyrille Coustal, Juliette Vanoverschelde, Ariane Lappara, Eric Assenat, Maxime Faure, Diego Tosi, Hélène Vernhet-Kovacsik, Audrey Agullo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2023-05-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/11/5/e004792.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!